HomeDSGN • NASDAQ
add
Design Therapeutics Inc
Previous close
$9.24
Day range
$9.23 - $9.56
Year range
$2.62 - $10.31
Market cap
537.17M USD
Avg Volume
405.53K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.72M | 8.05% |
Net income | -17.00M | -30.36% |
Net profit margin | — | — |
Earnings per share | -0.30 | -30.43% |
EBITDA | -19.16M | -19.03% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 205.97M | -18.93% |
Total assets | 211.77M | -19.06% |
Total liabilities | 12.05M | 31.32% |
Total equity | 199.72M | — |
Shares outstanding | 56.96M | — |
Price to book | 2.63 | — |
Return on assets | -22.21% | — |
Return on capital | -23.19% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -17.00M | -30.36% |
Cash from operations | -11.16M | -16.93% |
Cash from investing | 6.51M | 211.74% |
Cash from financing | 37.00K | 3,600.00% |
Net change in cash | -4.62M | 69.98% |
Free cash flow | -5.46M | -5.19% |
About
Founded
2017
Headquarters
Website
Employees
55
